2 of Pfizer and BioNTech’s coronavirus vaccine candidates have received “fast track” status from the FDA.
have received 'fast track' designation from the U.S. drug regulator, the companies said on Monday.
Pfizer's shares were up about 2% and U.S.-listed shares of BioNTech were up about 6% before the bell. Early data from the German trial of BNT162b1 are expected to be released in July, the companies said.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coronavirus updates: Pfizer, BioNTech vaccine candidates get 'fast track'; Germany aims to avoid second waveThe coronavirus has infected more than 12.91 million people around the world as of Monday, killing at least 569,128 people.
Read more »
Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' statusTwo experimental coronavirus vaccines jointly developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer have received 'fast track' designation from the U.S. drug regulator, the companies said on Monday.
Read more »
Stocks making the biggest moves in the premarket: PepsiCo, Analog Devices, Carnival, Pfizer & moreThe stocks making the biggest moves in premarket trading include PepsiCo, Analog Devices, Carnival, Pfizer, and more.
Read more »
Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' statusTwo experimental coronavirus vaccines jointly developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer have received 'fast track' designation from the U.S. drug regulator, the companies said on Monday.
Read more »
Coronavirus updates: Pfizer, BioNTech vaccine candidates get 'fast track'; Germany aims to avoid second waveThe coronavirus has infected more than 12.91 million people around the world as of Monday, killing at least 569,128 people.
Read more »
Bill Gates warns against coronavirus vaccine going to highest bidder — 'We'll have a deadlier pandemic'As countries and companies race to bring a Covid-19 vaccine to the market, concerns have risen about wealthier nations receiving more drugs than developing countries.
Read more »